Ancient Grains Linked to Improved Type 2 Diabetes Outcomes

Translate to Spanish or other 102 languages!

A new study suggests ancient grains like oats and buckwheat may help manage blood sugar and cholesterol in type 2 diabetes. Image for illustration purposes
A new study suggests ancient grains like oats and buckwheat may help manage blood sugar and cholesterol in type 2 diabetes. Image for illustration purposes
- Advertisement -
  • A new study suggests ancient grain consumption is associated with improved health outcomes for people with type 2 diabetes. 
  • Ancient grains like oats are rich in dietary fiber and phytochemicals that may help manage blood sugar and cholesterol. 
  • Experts recommend incorporating minimally refined grains into a healthy, balanced diet to reap the most benefits.

A new study highlights the potential benefits of including ancient grains in dietary patterns for people with diabetes.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/ancient-grains-may-help-treat-type-2-diabetes?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-05-06&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

What You Need to Know About Aortic Dissection

An aortic dissection – a tear in the inner layer of the main artery – is a life-threatening emergency. It can happen with little warning, as apparently was the case with U.S. Sen. Lindsey Graham. His sudden death at age 71 was preliminarily attributed to an aortic dissection stemming from plaque buildup in his arteries.

How Morning Meals Boost Grades and Energy

We all know mornings can be hectic with kids and sometimes that means they might skip breakfast before school, but that habit could hurt them in the long run.

FDA Launches Expedited IND Pilot to Speed Up Clinical Trials

The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot. Accelerating clinical trial timelines and eliminating regulatory hurdles to maintain American leadership in global medical innovation is a core priority for the Trump Administration.

Navigating Cardiovascular Health in Hispanic Communities

Cardiovascular disease is the leading cause of death for Hispanic and Latino people in the United States. But the challenges they face are hardly the whole story, say experts who helped write a new report on the heart health of these communities.
- Advertisement -